General Practice · New York, NY
NPI
1902030869
Since 2009
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
111 Wadsworth Ave
New York, NY, 10033
Phone (646) 682-7544
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,681
1,603 services
Medicare patients, 2024
28
Average age 68
Drug cost, 2024
$3.8M
5,186 prescriptions
Company payments, 2025
$132
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose M Lares-Guia was code 99212 (office e&m - established), 54 times for 23 patients. In total Jose M Lares-Guia billed 1,603 services in 11 codes, and Medicare paid $4,681.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Office | 54 | 23 | $38.61 | $2,085 |
By year: 2022 $133K for 64,035 services; 2023 $86K for 4,847 services; 2024 $4,681 for 1,603 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 258 | 51 | $8.40 | $2,167 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose M Lares-Guia prescribed most often to Medicare patients was Descovy (Emtricitabine/Tenofov Alafenam), with 302 prescriptions and refills. In total Jose M Lares-Guia wrote 5,186 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Descovy Emtricitabine/Tenofov Alafenam | 302 | 315 | 30 | $661K |
| Tivicay Dolutegravir Sodium | 256 | 272 | 30 | $737K |
| Isentress Raltegravir Potassium | 255 | 255 | 22 | $495K |
| Atorvastatin Calcium Generic | 254 | 274 | 25 | $1,400 |
| Valacyclovir Valacyclovir Hcl | 195 | 197 | 22 | $8,193 |
| Olmesartan Medoxomil Generic | 164 | 195 | 19 | $1,143 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 159 | 159 | 15 | $624K |
| Ritonavir Generic | 148 | 158 | 14 | $16K |
| Maraviroc Generic | 107 | 107 | Under 11 | $135K |
| Omega-3 Acid Ethyl Esters Generic | 107 | 115 | 11 | $2,039 |
| Etravirine Generic | 105 | 105 | Under 11 | $90K |
| Tamsulosin Hcl Generic | 98 | 104 | 11 | $691 |
| Darunavir Generic | 95 | 103 | Under 11 | $145K |
| Bupropion Xl Bupropion Hcl | 92 | 96 | Under 11 | $1,332 |
| Furosemide Generic | 76 | 84 | Under 11 | $152 |
Brand drugs: 1,623 claims; generic drugs: 3,527 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose M Lares-Guia $132 ($132 in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $106.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 4 | $106 |
| Mallinckrodt Hospital Products Inc. | 1 | $25.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.